Comparison of American Joint Committee on Cancer Pathological Stage T2a Versus T2b Urothelial Carcinoma: Analysis of Patient Outcomes in Organ Confined Bladder Cancer

Journal of Urology

Volumn 181, Issue 2, 2009, Pages 540-546

  Boudreaux Jr , Kelly J ^a   Clark, Peter E ^a   Lowrance, William T ^a   Rumohr, Jon A ^a   Barocas, Daniel A ^a   Cookson, Michael S ^a   Smith Jr , Joseph A ^a   Chang, Sam S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

carcinoma; mortality; neoplasm staging; urinary bladder; urothelium

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; UROTHELIAL BLADDER CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 58149203193     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.038     Document Type: Article

References (11)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
2. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Lippincott-Raven, Philadelphia 335-337
3. Jewett H.J. Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 67 (1952) 672
4. Dalbagni G., Genega E., Hashibe M., Zhang Z.F., Russo P., Herr H., et al. Cystectomy for bladder cancer: a contemporary series. J Urol 165 (2001) 1111
5. Shariat S.F., Karakiewicz P.I., Palapattu G.S., Lotan Y., Rogers C.G., Amiel G.E., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414
6. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
7. Cheng L., Neumann R.M., Scherer B.G., Weaver A.L., Leibovich B.C., Nehra A., et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 85 (1999) 2638
8. Girgin C., Sezer A., Delibas M., Sahin O., Oder M., and Dincel C. Impact of the level of muscle invasion in organ-confined bladder cancer. Urol Int 78 (2007) 145
9. Herranz Amo F., Verdu Tartajo F., Diez Cordero J.M., Bielsa Carrillo A., Garcia Burgos J., Subira Rios D., et al. Differences in survival of patients with bladder cancer depending on depth of muscle infiltration. Actas Urol Esp 25 (2001) 110
10. Tokgoz H., Turkolmez K., Resorlu B., Kose K., Tulunay O., and Beduk Y. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?. Int Braz J Urol 33 (2007) 777
11. Yu R.J., Stein J.P., Cai J., Miranda G., Groshen S., and Skinner D.G. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 176 (2006) 493